These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 15589636)

  • 21. Improvements in physical and mental domains of quality of life by anti-ischaemic drug and revascularisation treatment in elderly men and women with chronic angina.
    Buser MA; Buser PT; Kuster GM; Grize L; Pfisterer M;
    Heart; 2008 Nov; 94(11):1413-8. PubMed ID: 18208833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease.
    Javaid A; Steinberg DH; Buch AN; Corso PJ; Boyce SW; Pinto Slottow TL; Roy PK; Hill P; Okabe T; Torguson R; Smith KA; Xue Z; Gevorkian N; Suddath WO; Kent KM; Satler LF; Pichard AD; Waksman R
    Circulation; 2007 Sep; 116(11 Suppl):I200-6. PubMed ID: 17846304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness of coronary artery bypass surgery.
    Weinstein MC; Stason WB
    Circulation; 1982 Nov; 66(5 Pt 2):III56-66. PubMed ID: 6812979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness of the real-world use of drug-eluting stents at 9-month follow-up: results from the Sicilian DES Registry.
    Tamburino C; Barbagallo R; Capodanno D; di Matteo S; Colombo GL; Recchia M; Ciriminna S;
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):322-9. PubMed ID: 19430343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of an invasive strategy in unstable coronary artery disease; results from the FRISC II invasive trial. The Fast Revascularisation during InStability in Coronary artery disease.
    Janzon M; Levin LA; Swahn E
    Eur Heart J; 2002 Jan; 23(1):31-40. PubMed ID: 11741360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Five-year follow-up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II).
    Rodriguez AE; Baldi J; Fernández Pereira C; Navia J; Rodriguez Alemparte M; Delacasa A; Vigo F; Vogel D; O'Neill W; Palacios IF;
    J Am Coll Cardiol; 2005 Aug; 46(4):582-8. PubMed ID: 16098419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness of minimally invasive cardiac operations.
    Ferraris VA; Ferraris SP
    Heart Surg Forum; 2001; 4 Suppl 1():S30-4. PubMed ID: 11178305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HRQoL after coronary artery bypass grafting and percutaneous coronary intervention for stable angina.
    Loponen P; Luther M; Korpilahti K; Wistbacka JO; Huhtala H; Laurikka J; Tarkka MR
    Scand Cardiovasc J; 2009 Apr; 43(2):94-9. PubMed ID: 18819033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment decisions in stable coronary artery disease: insights from the Euro Heart Survey on Coronary Revascularization.
    Breeman A; Hordijk-Trion M; Lenzen M; Hoeks S; Ottervanger JP; Bertrand ME; Sechtem U; Zaliunas R; Legrand V; de Boer MJ; Stahle E; Mercado N; Wijns W; Boersma E;
    J Thorac Cardiovasc Surg; 2006 Nov; 132(5):1001-9. PubMed ID: 17059915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials.
    Mercado N; Wijns W; Serruys PW; Sigwart U; Flather MD; Stables RH; O'Neill WW; Rodriguez A; Lemos PA; Hueb WA; Gersh BJ; Booth J; Boersma E
    J Thorac Cardiovasc Surg; 2005 Aug; 130(2):512-9. PubMed ID: 16077421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term cost-effectiveness of early and sustained clopidogrel therapy for up to 1 year in patients undergoing percutaneous coronary intervention after presenting with acute coronary syndromes without ST-segment elevation.
    Mahoney EM; Mehta S; Yuan Y; Jackson J; Chen R; Gabriel S; Lamy A; Culler S; Caro J; Yusuf S; Weintraub WS;
    Am Heart J; 2006 Jan; 151(1):219-27. PubMed ID: 16368322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical characteristics, in-hospital outcomes and predictors of in-hospital mortality in patients with acute coronary syndromes without persistent ST-segment elevation assigned to early invasive treatment strategy].
    Szyguła-Jurkiewicz B; Wojnicz R; Trzeciak P; Niklewski T; Zembala M; Poloński L
    Przegl Lek; 2005; 62(5):265-9. PubMed ID: 16334529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coronary artery bypass surgery versus percutaneous coronary artery intervention in patients on chronic hemodialysis: does a drug-eluting stent have an impact on clinical outcome?
    Manabe S; Shimokawa T; Fukui T; Fumimoto KU; Ozawa N; Seki H; Takanashi S
    J Card Surg; 2009; 24(3):234-9. PubMed ID: 19438773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute coronary syndromes in Europe: 1-year costs and outcomes.
    Taylor MJ; Scuffham PA; McCollam PL; Newby DE
    Curr Med Res Opin; 2007 Mar; 23(3):495-503. PubMed ID: 17355731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of percutaneous coronary intervention and coronary artery bypass grafting after acute myocardial infarction complicated by cardiogenic shock: results from the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) trial.
    White HD; Assmann SF; Sanborn TA; Jacobs AK; Webb JG; Sleeper LA; Wong CK; Stewart JT; Aylward PE; Wong SC; Hochman JS
    Circulation; 2005 Sep; 112(13):1992-2001. PubMed ID: 16186436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease: six-year follow-up from the Stent or Surgery Trial (SoS).
    Booth J; Clayton T; Pepper J; Nugara F; Flather M; Sigwart U; Stables RH;
    Circulation; 2008 Jul; 118(4):381-8. PubMed ID: 18606919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health related quality of life after percutaneous coronary intervention versus coronary artery bypass graft surgery in patients with acute coronary syndromes without ST-segment elevation. 12-month follow up.
    Szygula-Jurkiewicz B; Zembala M; Wilczek K; Wojnicz R; Polonski L
    Eur J Cardiothorac Surg; 2005 May; 27(5):882-6. PubMed ID: 15848330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Economic impact of angina after an acute coronary syndrome: insights from the MERLIN-TIMI 36 trial.
    Arnold SV; Morrow DA; Lei Y; Cohen DJ; Mahoney EM; Braunwald E; Chan PS
    Circ Cardiovasc Qual Outcomes; 2009 Jul; 2(4):344-53. PubMed ID: 20031860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of coronary artery disease: coronary by-pass or balloon dilatation?].
    Heikkilä J; Järvinen A
    Duodecim; 2000; 116(19):2087-96. PubMed ID: 12017729
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.